Paloma Partners’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,625
| Closed | -$10.6K | – | 1172 |
|
|
2024
Q2 | $10.6K | Buy |
+29,625
| New | +$10.6K | ﹤0.01% | 782 |
|
|
2020
Q4 | – | Sell |
-41,710
| Closed | -$395K | – | 1887 |
|
|
2020
Q3 | $395K | Buy |
41,710
+30,402
| +269% | +$288K | 0.01% | 1169 |
|
|
2020
Q2 | $101K | Buy |
+11,308
| New | +$101K | ﹤0.01% | 1715 |
|
|
2017
Q1 | – | Sell |
-22,011
| Closed | -$67K | – | 1662 |
|
|
2016
Q4 | $67K | Buy |
+22,011
| New | +$67K | ﹤0.01% | 1461 |
|
|
2015
Q3 | – | Sell |
-50,137
| Closed | -$556K | – | 1549 |
|
|
2015
Q2 | $556K | Buy |
50,137
+37,379
| +293% | +$415K | 0.01% | 839 |
|
|
2015
Q1 | $200K | Buy |
+12,758
| New | +$200K | 0.01% | 972 |
|
|
2014
Q4 | – | Sell |
-12,600
| Closed | -$136K | – | 1222 |
|
|
2014
Q3 | $136K | Buy |
+12,600
| New | +$136K | 0.01% | 802 |
|